Overview
Semaglutide is a GLP-1 receptor agonist widely characterised in metabolic research.
Mechanism
Selective GLP-1 receptor activation. See published literature for receptor pharmacology and stability data.
Provided strictly for research purposes. Not for human use. No dosing guidance.